Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up - Fradet, Y; Bellmunt, J; Vaughn, DJ (Ann Oncol Off J Eur Soc Med Oncol, 2019)